New Vaccine Prolongs Life for Glioblastoma Patients

2023-01-20T16:35:21-05:00

A major phase III clinical trial has found that DCVax®-L, a dendritic cell brain tumor vaccine, can prolong the lives of patients diagnosed with new or recurrent glioblastomas.

New Vaccine Prolongs Life for Glioblastoma Patients2023-01-20T16:35:21-05:00

Zeroing in on Druggable Targets for Metastatic Breast Cancer

2022-03-03T20:25:38-05:00

Breast cancer is the second most common type of cancer to metastasize to the brain. Thankfully, targeted therapies are driving major advances in treatment and improving life expectancy from a number of months to a number of years. Oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center Bonni Lee Guerin, MD, shares the latest.

Zeroing in on Druggable Targets for Metastatic Breast Cancer2022-03-03T20:25:38-05:00

Clinical Trials Offer Patient Access to Groundbreaking Therapies

2021-04-26T10:29:19-04:00

Investigational clinical trials are at the heart of innovation in brain tumor treatment. At the Gerald J. Glasser Brain Tumor Center, we have a robust clinical trial research infrastructure in place.

Clinical Trials Offer Patient Access to Groundbreaking Therapies2021-04-26T10:29:19-04:00

Immunotherapy Clinical Trial Aims to Combat Brain Cancer

2022-03-30T12:34:30-04:00

A Phase 2/3 clinical trial called Toca 5 - investigating a retroviral gene therapy treatment in patients with recurrent brain cancer - is actively enrolling at Altair Health.

Immunotherapy Clinical Trial Aims to Combat Brain Cancer2022-03-30T12:34:30-04:00

Dr. Paul Saphier Leads New Jersey Arm of Global Clinical Trial to Improve the Standard of Care for Brain Bleeds

2022-03-30T12:34:33-04:00

Dr. Paul Saphier, a board-certified neurosurgeon and stroke specialist at Altair Health in Morristown, NJ, is helping spearhead an effort to advance what the medical community considers the best medical treatment for hemorrhagic strokes … and improve outcomes for patients.

Dr. Paul Saphier Leads New Jersey Arm of Global Clinical Trial to Improve the Standard of Care for Brain Bleeds2022-03-30T12:34:33-04:00
Go to Top